The Investment Thesis
Five forces converging into one ecosystem.
01
AI in Healthcare
Clinical AI is moving from pilots to production.
02
Genomics & Epigenetics
Cost curves enable population-scale interpretation.
03
Longevity Medicine
Preventive, biomarker-driven care is the new standard.
04
Personalized Supplements
Genotype-guided products drive retention.
05
Global Clinic Expansion
Master licensing scales without owning every clinic.
The Core Thesis
Data Moat
Each report, pathway and follow-up strengthens the platform.
Recurring Revenue
Supplements, RobAge tracking, clinic licenses and physician memberships.
Multi-Vertical Upside
Each vertical can stand alone while compounding holding value.
Global Licensing
Country representatives finance market development.
Clinical Intelligence Layer
AI converts molecular data into practical clinical action.
Multiple Exit Pathways
Labs, supplement majors, longevity groups, AI healthtech, IPO.
Investor Summary
A precision-health holding company
- Investment Category
- AI Precision Health Holding Company
- Stage
- Growth preparation / scalable platform stage
- Core Assets
- IP, AI workflows, scientific methodology, brand, training platform, international network
- Revenue Types
- SaaS · reports · supplements · licensing · franchise fees · education · concierge · API
- Expansion Model
- Holding + verticals + master licensees
- Investor Appeal
- Multi-product ecosystem with recurring revenue and global scalability